Professor Nancy Ip discusses her groundbreaking neuroscience research, focusing on neurotrophic factors and innovative ...

H.C. Wainwright analyst Patrick Trucchio has reiterated their bullish stance on VYGR stock, giving a Buy rating today. Patrick ...

The only approved treatments for Alzheimer’s disease are medications with limited effectiveness and a risk of severe, sometimes deadly, side effects. That’s why scientists search for therapies ...

Critical Path Institute (C-Path) today announced key leadership appointments: Diane Stephenson, Ph.D., has been promoted to Vice President of Neurology, and Nadine Tatton, Ph.D., has been welcomed as ...

MTC has, however, already been studied as an Alzheimer's therapy, so TauRx selected a low dose (4 mg taken twice a week) that it thought would discolour the urine, but not have any therapeutic effect.

Studies have not found evidence that aluminum contributes to Alzheimer’s disease development. But research is ongoing, and you could be a part of it. Alzheimer’s is a progressive disease that ...

This view of Alzheimer's as a circuit disorder that ultimately disrupts cognition is speculative, Lein stressed. But the new study's cellular mapping supports reframing Alzheimer's beyond just a ...

It is thought that people with Alzheimer's disease are more susceptible to infections than healthy people of the same age. As the diseases that cause dementia are very complex, it is unlikely that ...

For the first time, new drugs have been approved in the UK that can slow down memory and thinking decline in early Alzheimer’s disease. But research never stops! Here we explore three promising new ...

Maher, Pamela 2023. Ferroptosis in Health and Disease. p. 461. Alzheimer's Disease (AD) is a growing global public health challenge. The development of new therapies is urgently needed, and a complex ...

Beta-amyloid plaques are protein clumps that form in the brain and block the neural paths that send signals throughout the ...

It is estimated that men in the United States aged 65 years have a 19.5 percent chance of developing Alzheimer's disease during their lifetime, while the lifetime risk for women age 65 years is 21 ...